Ontology highlight
ABSTRACT:
SUBMITTER: Advani AS
PROVIDER: S-EPMC4188732 | biostudies-literature | 2014 Oct
REPOSITORIES: biostudies-literature
Advani Anjali S AS McDonough Shannon S Copelan Edward E Willman Cheryl C Mulford Deborah A DA List Alan F AF Sekeres Mikkael A MA Othus Megan M Appelbaum Frederick R FR
British journal of haematology 20140718 2
Inhibition of cholesterol synthesis and uptake sensitizes acute myeloid leukaemia (AML) blasts to chemotherapy. A Phase 1 study demonstrated the safety of high dose pravastatin given with idarubicin and cytarabine in patients with AML and also demonstrated an encouraging response rate. The Southwestern Oncology Group (SWOG) trial, SWOG S0919, was a Phase 2 trial evaluating the complete remission (CR) rate in a larger number of patients with relapsed AML treated with idarubicin, cytarabine and pr ...[more]